Innovotech (CVE:IOT) Hits New 1-Year Low – Should You Sell?
by Kim Johansen · The Markets DailyShares of Innovotech Inc. (CVE:IOT – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.10 and last traded at C$0.10, with a volume of 223914 shares changing hands. The stock had previously closed at C$0.11.
Innovotech Stock Up 5.0%
The company has a quick ratio of 5.81, a current ratio of 2.63 and a debt-to-equity ratio of 12.55. The business has a 50-day moving average price of C$0.15 and a 200-day moving average price of C$0.21. The firm has a market capitalization of C$5.72 million, a PE ratio of -15.42 and a beta of 2.62.
About Innovotech
Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.